Statements (34)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
gptkb:drug |
| gptkbp:approvedBy |
gptkb:European_Union
|
| gptkbp:ATCCode |
M05BX03
|
| gptkbp:brand |
Osseor
Protelos |
| gptkbp:CASNumber |
135459-87-9
|
| gptkbp:chemicalFormula |
C12H6N2O8SSr2
|
| gptkbp:compatibleWith |
gptkb:United_States
|
| gptkbp:containsElement |
gptkb:sulfur
gptkb:strontium carbon hydrogen nitrogen oxygen |
| gptkbp:contraindication |
ischemic heart disease
uncontrolled hypertension history of venous thromboembolism |
| gptkbp:developedBy |
gptkb:Servier
|
| gptkbp:discoveredBy |
late 1990s
|
| https://www.w3.org/2000/01/rdf-schema#label |
strontium ranelate
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:mechanismOfAction |
reduces bone resorption
stimulates bone formation |
| gptkbp:molecularWeight |
513.49 g/mol
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
nausea
diarrhea headache increased risk of cardiovascular events |
| gptkbp:usedFor |
treatment of osteoporosis
|
| gptkbp:withdrawn_in |
some countries due to safety concerns
|
| gptkbp:bfsParent |
gptkb:M05BX04
|
| gptkbp:bfsLayer |
8
|